215 related articles for article (PubMed ID: 26921336)
1. Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow.
Miftakhova R; Hedblom A; Semenas J; Robinson B; Simoulis A; Malm J; Rizvanov A; Heery DM; Mongan NP; Maitland NJ; Allegrucci C; Persson JL
Cancer Res; 2016 Apr; 76(8):2453-64. PubMed ID: 26921336
[TBL] [Abstract][Full Text] [Related]
2. Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.
Wegiel B; Bjartell A; Tuomela J; Dizeyi N; Tinzl M; Helczynski L; Nilsson E; Otterbein LE; Härkönen P; Persson JL
J Natl Cancer Inst; 2008 Jul; 100(14):1022-36. PubMed ID: 18612129
[TBL] [Abstract][Full Text] [Related]
3. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
4. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
[TBL] [Abstract][Full Text] [Related]
5. Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.
Bergström SH; Rudolfsson SH; Bergh A
Neoplasia; 2016 Mar; 18(3):152-61. PubMed ID: 26992916
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.
Ricci E; Mattei E; Dumontet C; Eaton CL; Hamdy F; van der Pluije G; Cecchini M; Thalmann G; Clezardin P; Colombel M
Prostate; 2013 Dec; 73(16):1738-46. PubMed ID: 24115186
[TBL] [Abstract][Full Text] [Related]
7. Aromatase-induced endogenous estrogen promotes tumour metastasis through estrogen receptor-α/matrix metalloproteinase 12 axis activation in castration-resistant prostate cancer.
Liang Z; Cao J; Tian L; Shen Y; Yang X; Lin Q; Zhang R; Liu H; Du X; Shi J; Zhang J
Cancer Lett; 2019 Dec; 467():72-84. PubMed ID: 31499120
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL
PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.
Kolonin MG; Sergeeva A; Staquicini DI; Smith TL; Tarleton CA; Molldrem JJ; Sidman RL; Marchiò S; Pasqualini R; Arap W
Cancer Res; 2017 Jun; 77(12):3144-3150. PubMed ID: 28428279
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
Yan J; De Melo J; Cutz JC; Aziz T; Tang D
Br J Cancer; 2014 May; 110(10):2593-603. PubMed ID: 24762960
[TBL] [Abstract][Full Text] [Related]
11. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Lippitt JM; Guzmán-Ramírez N; Hamdy FC; Eaton CL; Thalmann GN; Cecchini MG; Pelger RC; van der Pluijm G
Cancer Res; 2010 Jun; 70(12):5163-73. PubMed ID: 20516116
[TBL] [Abstract][Full Text] [Related]
12. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
13. A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.
Rossnagl S; Ghura H; Groth C; Altrock E; Jakob F; Schott S; Wimberger P; Link T; Kuhlmann JD; Stenzl A; Hennenlotter J; Todenhöfer T; Rojewski M; Bieback K; Nakchbandi IA
Cancer Res; 2018 Jan; 78(1):129-142. PubMed ID: 29066511
[TBL] [Abstract][Full Text] [Related]
14. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
15. A PSCA/PGRN-NF-κB-Integrin-α4 Axis Promotes Prostate Cancer Cell Adhesion to Bone Marrow Endothelium and Enhances Metastatic Potential.
Zhao Z; Li E; Luo L; Zhao S; Liu L; Wang J; Kang R; Luo J
Mol Cancer Res; 2020 Mar; 18(3):501-513. PubMed ID: 31722969
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.
Ye X; Huang X; Fu X; Zhang X; Lin R; Zhang W; Zhang J; Lu Y
J Hematol Oncol; 2023 May; 16(1):46. PubMed ID: 37138326
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
18. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
Wegiel B; Bjartell A; Ekberg J; Gadaleanu V; Brunhoff C; Persson JL
Oncogene; 2005 Sep; 24(42):6385-93. PubMed ID: 16007189
[TBL] [Abstract][Full Text] [Related]
19. P450-dependent enzymes as targets for prostate cancer therapy.
De Coster R; Wouters W; Bruynseels J
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
[TBL] [Abstract][Full Text] [Related]
20. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
